Evidence map›Paper›PMID 30425110›Full record

ReviewArchives of disease in childhood. Fetal and neonatal edition2019

Challenges and opportunities for antibiotic stewardship among preterm infants.

Sagori Mukhopadhyay, Shaon Sengupta, Karen M Puopolo

Abstract readReview
In one paragraph

Review in Archives of disease in childhood. Fetal and neonatal edition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Review
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sagori MukhopadhyayDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Shaon SenguptaDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Karen M PuopoloDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

Early life antibiotics, gut microbiome development, and risk of childhood obesityR01AI121383 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI GERBER, JEFFREY STEPHEN, KNIGHTS, DAN · 2016 to 2020
$3.7M
Incidence of atopy and childhood infections in uninfected term newborns with perinatal antibiotic exposureK23HD088753 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI MUKHOPADHYAY, SAGORI · 2017 to 2021
$790k
Role of Circadian Clock in Lung InflammationK08HL132053 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI SENGUPTA, SHAON · 2017 to 2020
$638k
NHLBI NIH HHS K08 HL132053NIAID NIH HHS R01 AI121383NICHD NIH HHS K23 HD088753
6 · The paper itself

Abstract

Antibiotic stewardship programmes aim to optimise antimicrobial use to prevent the emergence of resistance species and protect patients from the side effects of unnecessary medication. The high incidence of systemic infection and associated mortality from these infections leads neonatal providers to frequently initiate antibiotic therapy and make empiric antibiotic courses one of the main contributors of antibiotic use in the neonatal units. Yet, premature infants are also at risk for acute life-threatening complications associated with antibiotic use such as necrotising enterocolitis and for long-term morbidities such as asthma. In this review, we discuss specific aspects of antibiotic use in the very low birthweight preterm infants, with a focus on empiric use, that provide opportunities for stewardship practice. We discuss strategies to risk-stratify antibiotic initiation for the risk of early-onset sepsis, optimise empiric therapy duration and antibiotic choice in late-onset sepsis, and standardise decisions for stopping empiric therapy. Lastly, review the evolving role of biomarkers in antibiotic stewardship.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisAntimicrobial StewardshipDrug Administration ScheduleDrug UtilizationHumansInfant, Low Birth WeightInfant, NewbornInfant, PrematureInfant, Premature, DiseasesNeonatal SepsisPractice Patterns, Physicians'Risk AssessmentAnti-Bacterial Agentsantibiotic stewardshipprematurevery low birth weight

Identifiers

PMID30425110
PMCPMC6491257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.